The Blind Spot in COVID-19 Vaccination Policies: Under-Reported Adverse Events


  • Patrick Provost Faculty of Medicine, Université Laval



COVID-19 vaccine adverse effects, COVID vaccine safety, public health policy, risk-benefit assessment


Case reports involving two academic researchers suggest that adverse events (AEs) to COVID-19 messenger RNA (mRNA) vaccination are largely underreported due to numerous clinical, systemic, political and media factors. The lack of proper analysis and consideration of the reported AEs also suggests that these injections are not as safe as widely purported. The resulting biased risk-benefit assessment may only produce misinformed public health recommendations and misguided political decisions, thereby exposing the population to an underestimated risk, in possible violation of the precautionary principle and of the right to a free and informed consent. The possible mechanisms underlying AEs to COVID-19 vaccination raise serious concerns regarding the new vaccine application of the mRNA technology that need to be addressed before expanding it to other infectious diseases. The legal considerations of AE underreporting are also discussed, and recommendations are formulated. AEs to mRNA injections are a reality and need to be better assessed than heretofore, diagnosed and reported to public health authorities for follow-up investigation in order to inform policy decisions and updates to physician guidelines in an objective, scientifically based, independent, and transparent manner.

Author Biography

Patrick Provost, Faculty of Medicine, Université Laval

Full Professor, Faculty of Medicine, Université Laval; also, Researcher, Infectious and Immune Diseases Axis, CHU de Québec Research Center/CHUL Pavilion, 2705 Blvd Laurier, Room T1-65, Québec, QC, G1V 4G2, Canada


Appelbaum, J., Arnold, D. M., Kelton, J. G., Gernsheimer, T., Jevtic, S. D., Ivetic, N., Smith, J. W., & Nazy, I. (2022). SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia. Blood Advances, 6(7), 2250–2253.

Associated Press. (2022, January 3). Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older. AP NEWS.

Aung, K. M., Sjöström, A. E., von Pawel-Rammingen, U., Riesbeck, K., Uhlin, B. E., & Wai, S. N. (2016). Naturally occurring IgG antibodies provide innate protection against vibrio cholerae bacteremia by recognition of the outer membrane protein u. Journal of Innate Immunity, 8(3), 269–283.

Banoun, H., & Provost, P. (2023). A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccination. International Journal of Vaccine Theory, Practice, and Research, 2(2), 385–444.

Bardosh, K., Krug, A., Jamrozik, E., Lemmens, T., Keshavjee, S., Prasad, V., Makary, M. A., Baral, S., & Høeg, T. B. (2022). COVID-19 vaccine boosters for young adults: A risk-benefit assessment and five ethical arguments against mandates at universities (SSRN Scholarly Paper No. 4206070).

Basile, K., Maddocks, S., Kok, J., & Dwyer, D. E. (2020). Accuracy amidst ambiguity: False positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low. Pathology, 52(7), 809–811.

Baumeier, C., Aleshcheva, G., Harms, D., Gross, U., Hamm, C., Assmus, B., Westenfeld, R., Kelm, M., Rammos, S., Wenzel, P., Münzel, T., Elsässer, A., Gailani, M., Perings, C., Bourakkadi, A., Flesch, M., Kempf, T., Bauersachs, J., Escher, F., & Schultheiss, H.-P. (2022). Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series. International Journal of Molecular Sciences, 23(13), Article 13.

Benzi Cipelli, R., Giovannini, F., & Pisano, G. (2022). Dark-field microscopic analysis on the blood of 1,006 symptomatic persons after anti-COVID mRNA injections from Pfizer/BioNtech or Moderna. International Journal of Vaccine Theory, Practice, and Research, 2(2), 385–444.

Blaylock, R. L. (2021). Excitotoxicity (Immunoexcitotoxicity) as a Critical Component of the Cytokine Storm Reaction in Pulmonary Viral Infections, Including SARS-Cov-2. International Journal of Vaccine Theory, Practice, and Research, 1(2), 223–242.

Borger, P., Malhotra, B. R., Yeadon, M., Craig, C., McKernan, K., Steger, K., McSheehy, P., Angelova, L., Franchi, F., & Binder, T. (2020). External peer review of the RTPCR test to detect SARS-CoV-2 reveals 10 major scientific flaws at the molecular and methodological level: Consequences for false positive results. Research Gate. Doi, 10.

Borroni, E., Consonni, D., Cugno, M., Lombardi, A., Mangioni, D., Bono, P., Oggioni, M., Renteria, S. U., Bordini, L., Nava, C. D., Letzgus, M., Silverj, F. G., Castaldi, S., Rognoni, M., D’Oro, L. C., Carugno, M., Riboldi, L., Ceriotti, F., Bandera, A., … Pesatori, A. C. (2021). Side effects among healthcare workers from a large Milan universityhospital after second dose ofBNT162b2 mRNA COVID-19 vaccine. Medicina Del Lavoro, 112(6), 477–485.

Broudy, D., & Arakaki, M. (2020). Who wants to be a slave? The technocratic convergence of humans and data. Frontiers in Communication, 5.

Broudy, D., Bergman, T., & Ed Rankin. (2020, February 20). Telecom Jackboot: A 5G Kick to the Groin. OffGuardian.

CDC. (2018). Epidemiology of Vaccine Preventable Diseases (the “Pink Book”) (J. Hamborsky, A. Kroger, & C. S. Wolfe, Eds.; 13th ed.). Author.

CDC. (2022, November 22). Immunization Basics.

Chen, Y., Xu, Z., Wang, P., Li, X.-M., Shuai, Z.-W., Ye, D.-Q., & Pan, H.-F. (2022). New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology, 165(4), 386–401.

Children’s Health Defense (last). (2021). Planned Surveillance and Control by Global Technocrats: A Big-Picture Look at the Current Pandemic Beneficiaries. International Journal of Vaccine Theory, Practice, and Research, 1(2), 143–171.

Classen, J. B. (2021a). Review of COVID-19 Vaccines and the risk of chronic adverse events including neurological degeneration. Journal of Medicine; Clinical Research and Reviews, 7.

Classen, J. B. (2021b). US COVID-19 vaccines proven to cause more harm than good based on pivotal clinical trial data analyzed using the proper scientific endpoint, “all cause severe morbidity.” Microbiology & Infectious Diseases, 6.

Connors, J., Joyner, D., Mege, N., et al. Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. Research Square; 2022.

Cosentino, M., & Marino, F. (2022a). Understanding the pharmacology of COVID-19 mRNA vaccines: Playing dice with the spike? International Journal of Molecular Sciences, 23(18), Article 18.

Cosentino, M., & Marino, F. (2022b). The spike hypothesis in vaccine-induced adverse effects: Questions and answers. Trends in Molecular Medicine, 28(10), 797–799.

DARPA. (2022). In Wikipedia.

Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination: What do we know so far? Children, 8(7), Article 7.

Deutsche Wirtschaftsnachrichten. (2022, February 24). Impfung, Nebenwirkungen: Krankenkasse BKK schlägt Alarm [Vaccination, side effects: BKK health insurance raises the alarm].

E. P. I. C. Magazine. (2017, December 2). Vaccines are big business. Pharma is a trillion-dollar industry with vaccines accounting for $25 billion in annual sales. The Center for Disease Control’s decision to add a vaccine to the schedule can guarantee its manufacturer millions of customers and billions in revenue with minimal advertising or marketing costs and complete immunity from lawsuits. E.P.I.C. Empowering People, Inspiring Community.

Eisenhower, D. D. (1961). Eisenhower’s Farewell Address.

Fleming, D. R. M. (2021). Is COVID-19 a Bioweapon? A Scientific and Forensic Investigation. Skyhorse.

Garner, J. (2021). The Control Group: Pilot Survey of Unvaccinated Americans. The Control Group, PO Box 1504, Roseville, CA 95678, [email protected].

Garner, J. (2022). Health versus disorder, disease, and death: Unvaccinated persons are incommensurably healthier than vaccinated. International Journal of Vaccine Theory, Practice, and Research, 2(2), 670–686.

Gates, B. (2010, February 20). Bill Gates: Innovating to zero! | TED Talk |

Gates, B. (2020). Bill Gates: How Gene Editing, AI Can Benefit World’s Poorest—YouTube.

Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben-Tov, A., Cohen, D., Muhsen, K., Chodick, G., & Patalon, T. (2021). Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: Reinfections versus breakthrough infections (p. 2021.08.24.21262415). medRxiv.

Goldman, S., Bron, D., Tousseyn, T., Vierasu, I., Dewispelaere, L., Heimann, P., Cogan, E., & Goldman, M. (2021). Rapid progression of angioimmunoblastic T Cell lymphoma following BNT162b2 mRNA vaccine booster shot: A case report. Frontiers in Medicine, 8, 2409.

Guetzkow, J. (2022, February 18). The Israeli Ministry of Health Actually Did a Survey of Adverse Events after The Booster Dose [Substack newsletter]. Jackanapes Junction.

Guo, X. M., Cowan, M., Folsom, S., Ehimiaghe, E., Persenaire, C., Barber, E. L., & Tanner, E. J. (2021). Discrepancies between author- and industry-reported disclosures of financial relationships at an annual gynecologic oncology research meeting. Gynecologic Oncology, 160(1), 260–264.

Gutschi, M. (Director). (2022, November 2). Quality issues with mRNA Covid vaccine production.

Harari, Y. N. (2017). Homo Deus: A Brief History of Tomorrow. HarperCollins Publishers.

Harari, Y. N. (2020). Sapiens: A Graphic History: The Birth of Humankind (Illustrated edition). Harper Perennial.

Harari, Y. N. & TED (Directors). (2015, July 24). Why humans run the world.

Harari, Y. N., & World Economic Forum (Directors). (2022, March 7). Yuval Noah Harari, “We are now hackable animals.”

Hughes, D. A. (2022). What is in the so-called COVID-19 “vaccines”? Part 1: evidence of a global crime against humanity. International Journal of Vaccine Theory, Practice, and Research, 2(2), 455–586.

Inbar, R., Weiss, R., Tomljenovic, L., Arango, M.-T., Deri, Y., Shaw, C. A., Chapman, J., Blank, M., & Shoenfeld, Y. (2016). Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil. Vaccine, S0264410X16000165.

Inoue, K., Blumenthal, D. M., Elashoff, D., & Tsugawa, Y. (2019). Association between physician characteristics and payments from industry in 2015-2017: Observational study. BMJ Open, 9(9), e031010.

Jablonowski, K., & Hooker, B. S. (2022). Delayed vigilance: A comment on myocarditis in association with the COVID-19 injections. International Journal of Vaccine Theory, Practice, and Research, 2(2), 651.1-651.4.

Jeon, K.-Y. (2022). Moving and living micro-organisms in the COVID-19 vaccines—Prevention, early treatment cocktails for COVID-19 and detoxification methods to reduce sequels of COVID-19 vaccines. American Journal of Epidemiology and Public Health, 6(1), 001–006.

Kim, S. C., Sekhon, S. S., Shin, W.-R., Ahn, G., Cho, B.-K., Ahn, J.-Y., & Kim, Y.-H. (2022). Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Molecular & Cellular Toxicology, 18(1), 1–8.

Kampf, G. (2022). The epidemiological relevance of the COVID-19-vaccinated population is decreasing after booster vaccination, as shown by incidence rate ratios—Author’s reply. The Lancet Regional Health - Europe, 16, 100376.

Karanges, E. A., Ting, N., Parker, L., Fabbri, A., & Bero, L. (2020). Pharmaceutical industry payments to leaders of professional medical associations in Australia: “Focus on cardiovascular disease and diabetes.” Australian Journal of General Practice, 49(3), 151.;dn=002962661056506;res=IELIAC

Kennedy, R. F., Jr. (2021). The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health. Skyhorse Publishing.

Koch, W. F. (1939). The Chemistry of Natural Immunity (Revised). The Christopher Publishing House.

Kyrie, V., & Broudy, D. (2022). Cyborgs R Us: The bio-nano panopticon of injected bodies? International Journal of Vaccine Theory, Practice, and Research, 2(2), 355–383.

Latypova, A. (2022, October 1). Video: Pfizer and Moderna mRNA Vaccines Are Manufactured “Without Accountability and No Real Requirements for Safety or Efficacy”. Corona Investigative Committee with Alexandra Latypova—Global ResearchGlobal Research—Centre for Research on Globalization.

Lazarus, R., Klompas, M., Bernstein, S., & Harvard Pilgrim Health Care, Inc. (2010). Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP-VAERS) (p. 7). Harvard Pilgrim Health Care, Inc.

Lee, Y. M., Park, S., & Jeon, K.-Y. (2021). Foreign materials in blood samples of recipients of COVID-19 vaccines. International Journal of Vaccine Theory, Practice, and Research, 2(1), 249–265.

Liu, J. J., Bell, C. M., Matelski, J. J., Detsky, A. S., & Cram, P. (2017). Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: Retrospective observational study. BMJ, 359, j4619.

Lyons-Weiler, J. (2020). Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. Journal of Translational Autoimmunity, 3, 100051.

Lyons-Weiler, J. (2021). Balance of risk in COVID-19 reveals the extreme cost of false positives. International Journal of Vaccine Theory, Practice, and Research, 1(2), 209–222.

Massari, M., Spila-Alegiani, S., Morciano, C., Spuri, M., Marchione, P., Felicetti, P., Belleudi, V., Poggi, F. R., Lazzeretti, M., & Ercolanoni, M. (2022). Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy: A multi-database, self-controlled case series study. MedRxiv.

McLernon, L. M. (2022, August 10). Studies look at clotting, myocarditis tied to COVID-19 vaccines. CIDRAP.

Moderna TX, Inc. (2020, November 30). Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization | Moderna, Inc.

Moynihan, R., Albarqouni, L., Nangla, C., Dunn, A. G., Lexchin, J., & Bero, L. (2020). Financial ties between leaders of influential US professional medical associations and industry: Cross sectional study. BMJ-British Medical Journal, 369, m1505.

Nance, K. D., & Meier, J. L. (2021). Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines. ACS Central Science, 7(5), 748–756.

Nunez-Castilla, J., Stebliankin, V., Baral, P., Balbin, C. A., Sobhan, M., Cickovski, T., Mondal, A. M., Narasimhan, G., Chapagain, P., & Mathee, K. (2022). Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 Spike and human proteins. BioRxiv, 2021–08.

Ogata, A. F., Cheng, C.-A., Desjardins, M., Senussi, Y., Sherman, A. C., Powell, M., Novack, L., Von, S., Li, X., & Baden, L. R. (2022). Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients. Clinical Infectious Diseases, 74(4), 715–718.

Oller, J. W. (2021). Weaponized Pathogens and the SARS-CoV-2 Pandemic. International Journal of Vaccine Theory, Practice, and Research, 1(2), 172–208.

Oller, J. W., & Santiago, D. (2022). All cause mortality and COVID-19 injections: Evidence from 28 weeks of Public Health England “COVID-19 vaccine surveillance reports.” International Journal of Vaccine Theory, Practice, and Research, 2(2), 301–319.

Østein, K., Hovi, P., Husby, A., Härkänen, T., Selmer, R. M., Pihlström, N., Hansen, J. V., Nohynek, H., Gunnes, N., Sundström, A., Wohlfahrt, J., Nieminen, T. A., Grünewald, M., Gulseth, H. L., Hviid, A., & Ljung, R. (2022). Sars-Cov-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents. JAMA Cardiology, 7(6), 600–612.

Oster, M. E., Shay, D. K., Su, J. R., Gee, J., Creech, C. B., Broder, K. R., Edwards, K., Soslow, J. H., Dendy, J. M., Schlaudecker, E., Lang, S. M., Barnett, E. D., Ruberg, F. L., Smith, M. J., Campbell, M. J., Lopes, R. D., Sperling, L. S., Baumblatt, J. A., Thompson, D. L., … Shimabukuro, T. T. (2022). Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA, 327(4), 331–340.

Panda, S., & Ding, J. L. (2015). Natural antibodies bridge innate and adaptive immunity. The Journal of Immunology, 194(1), 13–20.

Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: A case series. Journal of Cardiovascular Magnetic Resonance, 23(1), 101.

Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., & Coupland, C. A. (2022). Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation, 146(10), 743–754.

Provost, P., Derome, N., Linard, C., Massie, B., & Caron, J. (2022). Potential conscientious objection to mRNA technology as preventive treatment for COVID-19. International Journal of Vaccine Theory, Practice, and Research, 2(2), 445–454.

Pugh, J., Savulescu, J., Brown, R. C. H., & Wilkinson, D. (2022). The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity. Journal of Medical Ethics, 48(6), 371–377.

Ruggeri, R. M., Giovanellla, L., & Campennì, A. (2022). SARS-CoV-2 vaccine may trigger thyroid autoimmunity: Real-life experience and review of the literature. Journal of Endocrinological Investigation.

Santiago, D. (2022a). A partial answer to the question posed by David A. Hughes, Phd, in the article: “What is in the so-called COVID-19 ‘vaccines’? Part 1: evidence of a global crime against humanity.” International Journal of Vaccine Theory, Practice, and Research, 2(2), 587–594.

Santiago, D. (2022b). Playing Russian Roulette with every COVID-19 injection: The deadly global game. International Journal of Vaccine Theory, Practice, and Research, 2(2), 619–650.

Schwab, K., & Malleret, T. (2020). COVID-19: The Great Reset. ISBN Agentur Schweiz.

Seneff, S., & Nigh, G. (2021). Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19. International Journal of Vaccine Theory, Practice, and Research, 2(1), 38–79.

Shaw, C. A. (2017). Neural Dynamics of Neurological Disease. John Wiley & Sons, Inc.

Shaw, C. A. (2020). Weaponizing the peer review system. International Journal of Vaccine Theory, Practice, and Research, 1(1), 11–26.

Shaw, C. A. (2021). Dispatches from the Vaccine Wars. Skyhorse Publishing.

Smith, R. (2005). Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies. PLOS Medicine, 2(5), e138.

Sun, C. L. F., Jaffe, E., & Levi, R. (2022). Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave. Scientific Reports, 12(1), 6978.

Tinari, S. (2021). The EMA COVID-19 data leak, and what it tells us about mRNA instability. Bmj, 372.

US Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. (2020). Emergency Use Authorization for Vaccines to Prevent COVID-19; Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 18.

US Government Accounting Office (US GAO). (2021, February 11). Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges | U.S. GAO.

Vojdani, A., & Kharrazian, D. (2020). Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clinical Immunology (Orlando, Fla.), 217, 108480.

Vojdani, A., Vojdani, E., & Kharrazian, D. (2021). Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: Implications for autoimmune diseases. Frontiers in Immunology, 11, 617089.

World Economic Forum, & Harari, Y. N. (Directors). (2018, January 25). Will the Future Be Human? - Yuval Noah Harari.

Yan, J., Grantham, M., Pantelic, J., Mesquita, P. J. B. de, Albert, B., Liu, F., Ehrman, S., Milton, D. K., & Consortium, E. (2018). Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proceedings of the National Academy of Sciences, 115(5), 1081–1086.

Yeadon, M. (2020). Lies, Damned Lies and Health Statistics–the Deadly Danger of False Positives. Lockdown Scept. Https://Lockdownsceptics. Org/Lies-Damned-Lies-and-Health-Statistics-the-Deadly-Danger-of-False-Positives/(Accessed 10.6. 20).




How to Cite

Provost, P. (2023). The Blind Spot in COVID-19 Vaccination Policies: Under-Reported Adverse Events. International Journal of Vaccine Theory, Practice, and Research, 3(1), 707–726.